News

Published November 11, 2024

LUND, Sweden, November 11, 2024 – Cellevate is excited to announce an exclusive global launch webinar on Wednesday, November 27, 2024. This event, held in collaboration with Cell & Gene Therapy Insights, will present the latest results from the validation program of Cellevate’s novel category of nanofiber-based cell culture systems designed for faster bioprocessing, more…

Published November 4, 2024

LUND, Sweden, November 4, 2024 – Cellevate is excited to announce its commercial launch of the world’s first nanofiber-based cell culture systems for viral vector production. The official global launch of Cellevat3d® nanofiber-based cell culture systems will take place at BIO-Europe in Stockholm, Sweden, on November 4-6, 2024. Join our launch event and company presentation…

Published October 25, 2024

LUND, Sweden – Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, is excited to announce the successful scale-up of its ground-breaking Cellevat3d® nanofiber microcarriers funded by Vinnova/STUNS Life Science. The study was performed at Testa Center in Uppsala, Sweden, in the 10-liter Xcellerex XDR-10 single-use stirred tank bioreactor (Cytiva). The…

Published October 3, 2024

LUND, Sweden – Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, is ready to pre-launch the world’s 1st nanofiber microcarrier for gene therapy at CPHI Milan, October 8-10, 2024. By providing up to 60 times more surface area for cell growth than conventional systems, Cellevat3d® nanofiber microcarriers increase yield and…

Published September 16, 2024

LUND, Sweden – Cellevate, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, announced today the successful closure of its recent second seed round led by Industrifonden in syndication with the European Innovation Council Fund (EIC Fund), securing a total of 3.2 MEUR. By achieving commercial and technical readiness in Q3 2024,…

Published September 6, 2024

LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems based on nanotechnology, is pleased to announce the appointment of Bettina Berendsen as Board of Directors Observer as well as Strategic Advisor. Bettina Berendsen is an executive leader with over 35 years of extensive experience in the global…

Published June 5, 2024

LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, is pleased to announce the appointment of Dr. Christel Fenge as Strategic Advisor. Dr. Fenge brings over 30 years of experience in various leadership roles across the bioprocessing and biopharmaceutical industry. Dr. Fenge previously…

Published March 15, 2024

LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, today announces a poster presentation at the Advanced Therapies congress in London on March 19-20, 2024. In the poster, we present positive results on the use of the 1st nanofiber-based microcarriers, Cellevat3dTM  microcarriers, in…

Published March 14, 2024

LUND, Sweden – Cellevate AB, an innovative biotech company developing the next generation of cell culture systems designed to revolutionize biomanufacturing, announces that Dr. Uwe Gottschalk has been elected as Chairman to its Board of Directors. The appointment follows the resignation of Mats Leifland, who served as Chairman of the Board until March 12, 2024….

Published March 14, 2024

LUND, Sverige – Cellevate AB, ett innovativt bioteknikföretag som utvecklar nästa generations cellodlingssystem designat för att revolutionera bioproduktion, meddelar att Dr. Uwe Gottschalk har valts till styrelseordförande. Dr. Gottschalk efterträder därmed Mats Leifland, som var styrelseordförande fram till den 12 mars 2024. Dr. Gottschalk bidrar med omfattande erfarenheter inom bioteknikområdet och har en framstående karriär…